[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.24, "open": 2.24, "dayLow": 2.23, "dayHigh": 2.44, "regularMarketPreviousClose": 2.24, "regularMarketOpen": 2.24, "regularMarketDayLow": 2.23, "regularMarketDayHigh": 2.44, "payoutRatio": 0.0, "beta": -0.141, "forwardPE": -1.7266188, "volume": 888110, "regularMarketVolume": 888110, "averageVolume": 1360459, "averageVolume10days": 1307240, "averageDailyVolume10Day": 1307240, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 209514256, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 3.2889, "twoHundredDayAverage": 6.137625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -147302688, "profitMargins": 0.0, "floatShares": 53712485, "sharesOutstanding": 87297600, "sharesShort": 5765453, "sharesShortPriorMonth": 6194900, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.066, "heldPercentInsiders": 0.00241, "heldPercentInstitutions": 1.0257, "shortRatio": 5.95, "shortPercentOfFloat": 0.072399996, "impliedSharesOutstanding": 87297600, "bookValue": 3.97, "priceToBook": 0.60453403, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -88853000, "trailingEps": -1.12, "forwardEps": -1.39, "enterpriseToEbitda": 1.451, "52WeekChange": -0.5020747, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 2.4, "targetHighPrice": 34.0, "targetLowPrice": 7.5, "targetMeanPrice": 19.0625, "targetMedianPrice": 19.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 358164000, "totalCashPerShare": 4.103, "ebitda": -101552000, "totalDebt": 1347000, "quickRatio": 22.886, "currentRatio": 23.138, "debtToEquity": 0.389, "returnOnAssets": -0.20134, "returnOnEquity": -0.29557, "freeCashflow": -43260376, "operatingCashflow": -70016000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "shortName": "Terns Pharmaceuticals, Inc.", "fiftyTwoWeekLowChangePercent": 0.28686333, "fiftyTwoWeekRange": "1.865 - 11.4", "fiftyTwoWeekHighChange": -9.0, "fiftyTwoWeekHighChangePercent": -0.7894737, "fiftyTwoWeekChangePercent": -50.207474, "earningsTimestamp": 1742501100, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.12, "epsForward": -1.39, "epsCurrentYear": -1.1962, "priceEpsCurrentYear": -2.0063536, "fiftyDayAverageChange": -0.8888998, "fiftyDayAverageChangePercent": -0.27027267, "twoHundredDayAverageChange": -3.7376251, "twoHundredDayAverageChangePercent": -0.6089693, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1744923406, "regularMarketTime": 1744920003, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 7.1428614, "regularMarketPrice": 2.4, "longName": "Terns Pharmaceuticals, Inc.", "postMarketChangePercent": 2.08333, "postMarketPrice": 2.45, "postMarketChange": 0.05, "regularMarketChange": 0.16000009, "regularMarketDayRange": "2.23 - 2.44", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1360459, "fiftyTwoWeekLowChange": 0.5350001, "marketState": "CLOSED", "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]